Outset Medical Inc. (OM) Tops Q4 EPS by 8c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
RBC Capital Remains Positive on Outset Medical Inc. (OM)
February 14, 2023 9:35 AM ESTRBC Capital analyst Shagun Singh reiterated an Outperform rating and $32.00 price target on Outset Medical Inc. (NASDAQ: OM).
The analyst comments "We caught up with the company twice since yesterday's release and believe the stock reaction is overdone because of the following reasons: (1) Q1 reflects typical seasonality for capital businesses, which represented 56% of the company's sales mix (consoles); in fact, we note that Q1 typically tends to be down sequentially for MedTech in general and... More
